Table 2.
Wu-ling-san group | Placebo group |
P value (% of change) |
|||||
Pretreatment | Post-treatment | % of change | Pretreatment | Post-reatment | % of change | ||
Urine volume(ml/day) | 2485.7 ± 386.5 | 2796.4 ± 525.7 | 13.9% | 2732.1 ± 797.9 | 2521.4 ± 762.7 | −5.7% | 0.02* |
Urine Ca (mg/day) | 249.5 ± 132.2 | 302.1 ± 106.5 | 44.6% | 266.3 ± 101.6 | 415.1 ± 290.7 | 62.7% | 0.62 |
Urine UA (mg/day) | 749.6 ± 336.6 | 893.5 ± 334.1 | 27.6% | 760.6 ± 246.2 | 849.3 ± 478.4 | 9.5% | 0.22 |
Urine Cr (mg/dl) | 59.1 ± 21.7 | 71.1 ± 24.4 | 42.9% | 66.0 ± 33.5 | 80.4 ± 27.6 | 36.6% | 0.84 |
Urine PH | 6.6 ± 0.6 | 6.5 ± 0.7 | −0.02% | 6.3 ± 0.8 | 6.3 ± 0.7 | 0.6% | 0.91 |
24hr Urine Ccr (ml/min) | 89.2 ± 26.4 | 107.5 ± 30.9 | 26.2% | 133.4 ± 37.1 | 114.1 ± 44.0 | 14.5% | 0.53 |
Data presented as mean ±SD
Percentage of change between groups P < 0.05 (independent t-test)